These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9751616)

  • 1. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.
    Gayther SA; Gorringe KL; Ramus SJ; Huntsman D; Roviello F; Grehan N; Machado JC; Pinto E; Seruca R; Halling K; MacLeod P; Powell SM; Jackson CE; Ponder BA; Caldas C
    Cancer Res; 1998 Sep; 58(18):4086-9. PubMed ID: 9751616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin germline mutations in familial gastric cancer.
    Guilford P; Hopkins J; Harraway J; McLeod M; McLeod N; Harawira P; Taite H; Scoular R; Miller A; Reeve AE
    Nature; 1998 Mar; 392(6674):402-5. PubMed ID: 9537325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.
    Guilford PJ; Hopkins JB; Grady WM; Markowitz SD; Willis J; Lynch H; Rajput A; Wiesner GL; Lindor NM; Burgart LJ; Toro TT; Lee D; Limacher JM; Shaw DW; Findlay MP; Reeve AE
    Hum Mutat; 1999; 14(3):249-55. PubMed ID: 10477433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.
    Kim HC; Wheeler JM; Kim JC; Ilyas M; Beck NE; Kim BS; Park KC; Bodmer WF
    Gut; 2000 Aug; 47(2):262-7. PubMed ID: 10896919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
    Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
    Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of E-cadherin germ-line alterations with prostate cancer.
    Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
    Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A germline E-cadherin mutation in a family with gastric and colon cancer.
    Salahshor S; Hou H; Diep CB; Loukola A; Zhang H; Liu T; Chen J; Iselius L; Rubio C; Lothe RA; Aaltonen L; Sun XF; Lindmark G; Lindblom A
    Int J Mol Med; 2001 Oct; 8(4):439-43. PubMed ID: 11562785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer.
    Stone J; Bevan S; Cunningham D; Hill A; Rahman N; Peto J; Marossy A; Houlston RS
    Br J Cancer; 1999 Apr; 79(11-12):1935-7. PubMed ID: 10206317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of familial gastric cancer in Tuscany, a region in Italy.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Suriano G; Vindigni C; Berardi A; Garosi L; De Stefano A; Leoncini L; Seruca R; Pinto E
    Oncology; 2007; 72(3-4):243-7. PubMed ID: 18185018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.